ICMR receives proposal from NMCG to test Ganga water for Covid-19 treatment
Team Udayavani, May 4, 2020, 10:06 AM IST
Indian Medical Research Council (ICMR) has received a proposal to conduct clinical trials on Ganga water to examine if it can be used to treat patients infected with Covid-19.
The proposal was sent by The National Mission for Clean Ganga (NMCG), an arm of the Jal Shakti Ministry. It was forwarded after apex research body after Atulya Ganga, an organisation comprising Army Veterans, requested Ministry to conduct clinical trials on the holy water.
The letter submitted by Atulya Ganga claimed that there are several species of bacteriophages in the upper stretches of the Ganga.
“In Ganges, scientists have discovered bacteriophages, and named it Ninja Virus, popularly known as Gangtva. Phages, as they are also called, are viruses that specifically target bacteria and are also extremely strain specific,” it stated
Major Manoj Keshwar (retd), founder of Atulya Ganga said that India is blessed to have a holy river like Ganga and there are scientific references to suggest that these phages have anti-microbial properties and could potentially destroy bacteria.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Indo-Pak war veteran Havaldar Baldev Singh passes away in Rajouri at 93
Shah launches ‘Bharatpol’ for international police assistance, asks agencies to use modern tech
Navy divers to be engaged in rescue of workers trapped in Assam coal mine
Kerala police records actress Honey Rose’s statement
HMPV: Centre asks states to increase surveillance for respiratory diseases
MUST WATCH
Latest Additions
Indo-Pak war veteran Havaldar Baldev Singh passes away in Rajouri at 93
Shah launches ‘Bharatpol’ for international police assistance, asks agencies to use modern tech
Wamiqa Gabbi joins Adivi Sesh in ‘Goodachari 2’
Man injured in accidental gunshot at Vamanjoor
Navy divers to be engaged in rescue of workers trapped in Assam coal mine
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.